Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2025-12-25 @ 3:00 AM
NCT ID:
NCT03537833
Eligibility Criteria:
Inclusion criteria :
* Patients who receive a pemetrexed-based chemotherapy regimen for the treatment of non-small cell lung cancer (NSCLC) or mesothelioma,
* Patients who consent to participate,
* Patients for whom it is possible to characterize the consumption of proton pump inhibitors with name of the PPI and dosage.
Exclusion criteria :
* Patients who receive pemetrexed out of intravenous of for another condition than NSCLC or mesothelioma
* Patients under 18 or who refused the participation in the data collection,
* Patient previously treated by a pemetrexed-based chemotherapy,
* Patients who first receive a pemetrexed-based regimen with an initial dose adjustment (\<500 mg/m²)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03537833
Study Brief:
Protocol Section:
NCT03537833